A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Bone and Soft Tissue Tumors
Clinical trial NCT05851456 · UNKNOWN
Trial details
- NCT number
- NCT05851456
- Sponsor
- Shanghai Yunying Medical Technology
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-10
- Primary completion
- 2025-04-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.